Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentin Voillet

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.
Journal of Leukocyte Biology|July 22, 2022
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responsesOne B Dintwe, Stephen C De Rosa, Yunda Huang, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Nature Medicine|June 26, 2019
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplantAude G Chapuis, Daniel N Egan, Merav Bar, et al.
Nature Communications|June 5, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Egan, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2022
An In Vivo Model of Human Macrophages in Metastatic MelanomaValentin Voillet, Trisha R Berger, Kelly M McKenna, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.
Journal of Leukocyte Biology|July 22, 2022
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responsesOne B Dintwe, Stephen C De Rosa, Yunda Huang, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Eagan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Nature Medicine|June 26, 2019
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplantAude G Chapuis, Daniel N Egan, Merav Bar, et al.
Nature Communications|June 5, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistenceFrancesco Mazziotta, Lauren E Martin, Daniel N Egan, et al.
Pageof 4